April N. Naegeli

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease

Bruce E. Sands, Laurent Peyrin‐Biroulet, Jarosław Kierkuś et al. · Gastroenterology · 2021 · 149 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +12

Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis

Caitriona Ryan, Alan Menter, Lyn Guenther et al. · British Journal of Dermatology · 2018 · 119 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Rising Economic Impact of <i>Clostridium difficile</i>-Associated Disease in Adult Hospitalized Patient Population

Xiaoyan Song, John G. Bartlett, Kathleen Speck et al. · Infection Control and Hospital Epidemiology · 2008 · 106 citations

Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +12

Psychometric properties of the Itch Numeric Rating Scale in patients with moderate‐to‐severe plaque psoriasis

Alexa B. Kimball, April N. Naegeli, Emily Edson‐Heredia et al. · British Journal of Dermatology · 2016 · 93 citations · Full text

Nursing, Dermatology, Item Response Theory +15

The Worst Itch Numeric Rating Scale for patients with moderate to severe plaque psoriasis or psoriatic arthritis

April N. Naegeli, Emuella Flood, Jennifer Tucker et al. · International Journal of Dermatology · 2014 · 71 citations

Medicine, Dermatology, Dermatopathology +13